Precision medicines biotech Relay Therapeutics is shedding about 10% of its workforce in efforts to streamline the ...
Pentixapharm has brought in almost 20 million euros ($22 million) from an IPO, with the German biotech earmarking the ...
One of those companies, a contract research organization focused on genetic medicines called Franklin Biolabs, officially ...
Kurma plans to raise a total of 250 million euros ($276 million) for the fund, dubbed Biofund IV, which would make it the ...
The digital pathology developer Proscia is launching an artificial intelligence toolkit for life science researchers, ...
Septerna is about to find out how a biotech without “any meaningful clinical data” fares in the late 2024 IPO market. | ...
Legend Biotech appears to be on a mission to shake up its cell therapy development. | A week after signing up to collaborate ...
Siemens Healthineers has received a new go-ahead from the FDA for what the company describes as its first completely ...
GigaGen’s prior work with the DOD produced polyclonal antibodies that can neutralize two botulinum neurotoxins, which are ...
Frazier Life Sciences has sourced a further $630 million for its fund focused on small and mid-cap biotechs. | Frazier Life ...
The COVID-19 pandemic made the public acutely aware of how vulnerable their noses are. | The COVID-19 pandemic made us ...
Big Pharma is investing heavily in AI to slash development timelines and foster innovation. | Big Pharma is investing heavily ...